YEE-CHUN CHEN
Also known as: 陳宜君
Research areas: Medicine · Infectious Diseases · Antifungal resistance and susceptibility · Antibiotic Resistance in Bacteria · Infection Control in Healthcare
0000-0002-1816-9010
About
Dr. Chen is one of the nation's leaders in medical mycology and infection control. Her research focus includes clinical and molecular epidemiology of invasive fungal diseases, surveillance of healthcare-associated infection and medical informatics, the development of new diagnostic and therapeutic strategies for invasive fungal infections, and pathogenesis of Candida infection. She initiates and chairs the Asia Fungal Working Group of the International Society for Human and Animal Mycology. She is PI or co-PI of a series multicenter, clinical and molecular epidemiological studies of fungal infections in Asia as well in Taiwan. She has authored or coauthored more than 200 peer-reviewed journal articles such as Clinical Infectious Diseases, Emerging Infection Diseases, Journal of Antimicrobial Chemotherapy, J Med Internet Res, PLoS One, Journal of Clinical Microbiology, Medical Mycology, Infection Control and Hospital Epidemiology, Journal of Hospital Infection, and Journal of the Formosan Medical Association.
In order to enhance awareness of invasive fungal infection, to improve quality of medical care and laboratory practice, and to facilitate research, she chair, design and promote continued education programs, including Medical Mycology Training Network in Asia and in Taiwan, and Asia CARE meeting. Dr. Chen has received several achievement awards, including personal academic awards from The Infectious Diseases Society of Taiwan and Formosa Medical Association, and, on behalf of National Taiwan University Hospital, quality improvement awards from CDC and Taipei City Government; Asia Pacific Hand Hygiene Excellent Award (developed country category) from Asia-Pacific Society of Infection Control and WHO Collaborating Centre on Patient Safety, Switzerland. She is a consultant or committee member at the Ministry of Health and Welfare, CDC, TFDA, and Taipei City Government.
Employment
Employment history is unavailable.
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (349)
- Treatment and outcome of chronic disseminated candidiasis in the era of antifungal prophylaxis: a retrospective multicentre cohort of 111 patients Save
- Invasive pulmonary aspergillosis caused by a rare species of Aspergillus turcosus: case report and literature review Save
- A novel application of the interferon-gamma release assay (IGRA) among end-stage heart failure patients awaiting heart transplantation Save
- Linezolid versus daptomycin for VRE bloodstream infections in patients with malignancy: The impact of neutropenia on outcomes Save
- Treatment outcomes of daptomycin- and vancomycin-resistant Enterococcus faecium bloodstream infection Save
- Epidemiology and Clinical Features of Cryptococcosis Among Individuals Without HIV Infection: An Observational International Multicenter Study (MSG-11) Save
- Voriconazole as a Secondary Prophylaxis for Invasive Fungal Infections in Allogeneic Hematopoietic Stem Cell Transplantation: Real-world Evidence From a Major Transplantation Center in Taiwan Save
- Letermovir Prophylaxis for CMV DNAemia/Disease after HLA‐Mismatched HSCT: A Retrospective Real‐World Analysis with Overlap Propensity Score Weighting Save
- Assessment of the molecular identification algorithm and its impact on antifungal susceptibilities against clinical Fusarium isolates: a multicentre study in Taiwan, 2011–2023 Save
- Integrative Analysis of miR-21, PTEN, and Immune Signatures in Colorectal Cancer Save
- Management of mould pneumonia in resource-limited settings in Asia: A Delphi-based consensus statement by the Asia Fungal Working Group Save
- Impact of empiric anti-VRE therapy on survival in vancomycin-resistant enterococcal bloodstream infection Save
- Managing Helicobacter pylori as an Infectious Disease: Implementation of Antimicrobial Stewardship Save
- Suboptimal response to combination therapy with tixagevimab/cilgavimab and remdesivir for persistent SARS-CoV-2 infections in immunocompromised patients—authors’ response Save
- Implication of genotypes for prognosis of Candida glabrata bloodstream infections Save
- Suboptimal response to combination therapy with tixagevimab/cilgavimab and remdesivir for persistent SARS-CoV-2 infections in immunocompromised patients Save
- Managing Patients with Immune-Mediated Inflammatory Diseases on Disease-Modifying Antirheumatic Drug Therapy in a COVID-19 Endemic World: A Narrative Review and Expert Insights Save
- The incidences and clinical outcomes of cryptococcosis in Taiwan: A nationwide, population-based study, 2002–2015 Save
- Environment contamination and intra-hospital spread of COVID-19 in a tertiary care Hospital in Taiwan Save
- Impact of coronavirus disease 2019 (COVID-19) on antimicrobial resistance among major pathogens causing healthcare-associated infection Save